V028-2539 Screening compound: N-(4-{[3,6-dimethyl-1-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)-2-methylpropanamide

V028-2539 Screening compound: N-(4-{[3,6-dimethyl-1-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)-2-methylpropanamide
V028-2539 Screening compound: N-(4-{[3,6-dimethyl-1-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)-2-methylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-2539
N-(4-{[3,6-dimethyl-1-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)-2-methylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-2539

Molecular Formula

C24H32N6O (C24 H32 N6 O)

Compound Name

N-(4-{[3,6-dimethyl-1-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)-2-methylpropanamide

IUPAC name

N-(4-{[36-dimethyl-1-(3-methylphenyl)-1H-pyrazolo[34-d]pyrimidin-4-yl]amino}cyclohexyl)-2-methylpropanamide

SMILES

CC(C)C(NC(CC1)CCC1Nc1nc(C)nc2c1c(C)nn2-c1cc(C)ccc1)=O

InChI

InChI=1S/C24H32N6O/c1-14(2)24(31)28-19-11-9-18(10-12-19)27-22-21-16(4)29-30(23(21)26-17(5)25-22)20-8-6-7-15(3)13-20/h6-8,13-14,18-19H,9-12H2,1-5H3,(H,28,31)(H,25,26,27)

InChI Key

BZLDQRNIHAQNBM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD13968035

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

420.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.188

Distribution Coefficient, logD

3.830

Water Solubility, LogSw

-4.47

Polar Surface Area

68.020

Acid Dissociation Constant (pKa)

15.43

Base Dissociation Constant (pKb)

7.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

V028-2539 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

CNS Targets (44014 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V028-2539 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-2539?
Check Price and Availability of V028-2539, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-2539 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-2539
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-2539
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-2539 available by request